- 5001-10,000 Employees
- Based in Valby, Europe
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension…More
Most Recent Responsibility Report
2022 Sustainability Report
Report Locked. Lundbeck A/S has reached its limit for free report views.
Lundbeck A/S does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Lundbeck A/S Sustainability Report, Lundbeck A/S Corporate Social Responsibility Report, Lundbeck A/S CSR Report, Lundbeck A/S Corporate Responsibility, Lundbeck A/S CR Report, Lundbeck A/S Citizenship Report, Lundbeck A/S ESG Report, and Lundbeck A/S Environmental Report online.